The table below shows Aptevo Therapeutics Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
-
-
-
-
-
-
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$3.92M
$4.04M
$3.33M
$3.63M
$3.10M
$3.64M
SG&A
APVO annual revenue (10-K history)
Aptevo Therapeutics Inc. reported annual revenue of $3.11M for fiscal year 2022. That is down 74.7% from $12.29M in fiscal 2021. Over the 8 fiscal years shown, annual revenue declined from $33.60M (FY 2015) to $3.11M. Figures come from the company's audited annual reports as filed with the SEC.